Literature DB >> 23892404

Integration of pharmacometabolomic and pharmacogenomic approaches reveals novel insights into antiplatelet therapy.

J P Lewis1, L M Yerges-Armstrong, S Ellero-Simatos, A Georgiades, R Kaddurah-Daouk, T Hankemeier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23892404      PMCID： PMC4116100          DOI： 10.1038/clpt.2013.153

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  5 in total

1.  Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate.

Authors:  X M Xu; L Sansores-Garcia; X M Chen; N Matijevic-Aleksic; M Du; K K Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  The genetic response to short-term interventions affecting cardiovascular function: rationale and design of the Heredity and Phenotype Intervention (HAPI) Heart Study.

Authors:  Braxton D Mitchell; Patrick F McArdle; Haiqing Shen; Evadnie Rampersaud; Toni I Pollin; Lawrence F Bielak; Cashell Jaquish; Julie A Douglas; Marie-Hélène Roy-Gagnon; Paul Sack; Rosalie Naglieri; Scott Hines; Richard B Horenstein; Yen-Pei C Chang; Wendy Post; Kathleen A Ryan; Nga Hong Brereton; Ruth E Pakyz; John Sorkin; Coleen M Damcott; Jeffrey R O'Connell; Charles Mangano; Mary Corretti; Robert Vogel; William Herzog; Matthew R Weir; Patricia A Peyser; Alan R Shuldiner
Journal:  Am Heart J       Date:  2008-03-05       Impact factor: 4.749

3.  Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics.

Authors:  Y Ji; S Hebbring; H Zhu; G D Jenkins; J Biernacka; K Snyder; M Drews; O Fiehn; Z Zeng; D Schaid; D A Mrazek; R Kaddurah-Daouk; R M Weinshilboum
Journal:  Clin Pharmacol Ther       Date:  2010-11-24       Impact factor: 6.875

4.  Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics.

Authors:  Ryan Abo; Scott Hebbring; Yuan Ji; Hongjie Zhu; Zhao-Bang Zeng; Anthony Batzler; Gregory D Jenkins; Joanna Biernacka; Karen Snyder; Maureen Drews; Oliver Fiehn; Brooke Fridley; Daniel Schaid; Naoyuki Kamatani; Yusuke Nakamura; Michiaki Kubo; Taisei Mushiroda; Rima Kaddurah-Daouk; David A Mrazek; Richard M Weinshilboum
Journal:  Pharmacogenet Genomics       Date:  2012-04       Impact factor: 2.089

5.  Purine pathway implicated in mechanism of resistance to aspirin therapy: pharmacometabolomics-informed pharmacogenomics.

Authors:  L M Yerges-Armstrong; S Ellero-Simatos; A Georgiades; H Zhu; J P Lewis; R B Horenstein; A L Beitelshees; A Dane; T Reijmers; T Hankemeier; O Fiehn; A R Shuldiner; R Kaddurah-Daouk
Journal:  Clin Pharmacol Ther       Date:  2013-06-11       Impact factor: 6.875
  5 in total
  13 in total

Review 1.  Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine.

Authors:  R Kaddurah-Daouk; R Weinshilboum
Journal:  Clin Pharmacol Ther       Date:  2015-06-04       Impact factor: 6.875

Review 2.  The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19.

Authors:  Yao Yang; Joshua P Lewis; Jean-Sébastien Hulot; Stuart A Scott
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-07-14       Impact factor: 4.481

Review 3.  Metabolomics: A Tool Ahead for Understanding Molecular Mechanisms of Drugs and Diseases.

Authors:  Neel Jayesh Shah; Srinivasamurthy Sureshkumar; Deepak Gopal Shewade
Journal:  Indian J Clin Biochem       Date:  2014-07-15

4.  Pharmacometabolomics of l-carnitine treatment response phenotypes in patients with septic shock.

Authors:  Michael A Puskarich; Michael A Finkel; Alla Karnovsky; Alan E Jones; Julie Trexel; Brooke N Harris; Kathleen A Stringer
Journal:  Ann Am Thorac Soc       Date:  2015-01

5.  Pharmacometabolomics informs Pharmacogenomics.

Authors:  Drew Neavin; Rima Kaddurah-Daouk; Richard Weinshilboum
Journal:  Metabolomics       Date:  2016-07-01       Impact factor: 4.290

6.  Pharmacometabolomic Assessments of Atenolol and Hydrochlorothiazide Treatment Reveal Novel Drug Response Phenotypes.

Authors:  D M Rotroff; M H Shahin; S B Gurley; H Zhu; A Motsinger-Reif; M Meisner; A L Beitelshees; O Fiehn; J A Johnson; M Elbadawi-Sidhu; R F Frye; Y Gong; L Weng; R M Cooper-DeHoff; R Kaddurah-Daouk
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-10-29

7.  Metabolomics enables precision medicine: "A White Paper, Community Perspective".

Authors:  Richard D Beger; Warwick Dunn; Michael A Schmidt; Steven S Gross; Jennifer A Kirwan; Marta Cascante; Lorraine Brennan; David S Wishart; Matej Oresic; Thomas Hankemeier; David I Broadhurst; Andrew N Lane; Karsten Suhre; Gabi Kastenmüller; Susan J Sumner; Ines Thiele; Oliver Fiehn; Rima Kaddurah-Daouk
Journal:  Metabolomics       Date:  2016-09-02       Impact factor: 4.290

Review 8.  The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics.

Authors:  Arwa M Amin; Lim Sheau Chin; Dzul Azri Mohamed Noor; Muhamad Ali Sk Abdul Kader; Yuen Kah Hay; Baharudin Ibrahim
Journal:  Cardiol Res Pract       Date:  2017-03-21       Impact factor: 1.866

9.  Oxylipid Profile of Low-Dose Aspirin Exposure: A Pharmacometabolomics Study.

Authors:  Sandrine Ellero-Simatos; Amber L Beitelshees; Joshua P Lewis; Laura M Yerges-Armstrong; Anastasia Georgiades; Adrie Dane; Amy C Harms; Katrin Strassburg; Faisa Guled; Margriet M W B Hendriks; Richard B Horenstein; Alan R Shuldiner; Thomas Hankemeier; Rima Kaddurah-Daouk
Journal:  J Am Heart Assoc       Date:  2015-10-26       Impact factor: 5.501

10.  Pharmacometabolomic Assessment of Metformin in Non-diabetic, African Americans.

Authors:  Daniel M Rotroff; Noffisat O Oki; Xiaomin Liang; Sook Wah Yee; Sophie L Stocker; Daniel G Corum; Michele Meisner; Oliver Fiehn; Alison A Motsinger-Reif; Kathleen M Giacomini; Rima Kaddurah-Daouk
Journal:  Front Pharmacol       Date:  2016-06-14       Impact factor: 5.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.